Horizon Therapeutics
HZNP
#767
Rank
A$39.94 B
Marketcap
$174.44
Share price
0.00%
Change (1 day)
3.19%
Change (1 year)

Horizon Therapeutics (HZNP) - Cash on Hand

Cash on Hand as of June 2023 : A$3.69 B

According to Horizon Therapeutics 's latest financial reports the company has A$3.69 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Horizon Therapeutics - Cash on Hand chart (from 2009 to 2023)

Cash on Hand by year

Year Cash on Hand Change
2022-12-31A$3.45 B59.08%
2021-12-31A$2.17 B-19.48%
2020-12-31A$2.69 B76.29%
2019-12-31A$1.53 B12.55%
2018-12-31A$1.36 B41.35%
2017-12-31A$0.96 B36.28%
2016-12-31A$0.70 B-40.16%
2015-12-31A$1.18 B342.27%
2014-12-31A$0.26 B195.73%
2013-12-31A$90.23 M-10.12%
2012-12-31A$0.10 B472.95%
2011-12-31A$17.52 M229.49%
2010-12-31A$5.31 M-33.57%
2009-12-31A$8 M-60.69%
2008-12-31A$20.36 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
A$13.95 B 277.38%๐Ÿ‡บ๐Ÿ‡ธ USA
A$10.61 B 187.10%๐Ÿ‡ฌ๐Ÿ‡ง UK
A$10.65 B 188.12%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.70 B-53.94%๐Ÿ‡ฎ๐Ÿ‡ณ India
A$17.02 B 360.68%๐Ÿ‡บ๐Ÿ‡ธ USA